ALLIANCEBERNSTEIN L.P. - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$373,860
-19.8%
124,6200.0%0.00%
Q2 2023$466,079
+55.5%
124,620
+39.2%
0.00%
Q1 2023$299,825
-26.9%
89,500
+4.9%
0.00%
Q4 2022$410,293
-10.0%
85,300
+6.5%
0.00%
Q3 2022$456,000
-19.9%
80,1000.0%0.00%
Q2 2022$569,000
-1.6%
80,1000.0%0.00%
Q1 2022$578,000
-19.0%
80,100
+0.3%
0.00%
Q4 2021$714,000
-78.9%
79,900
-17.0%
0.00%
-100.0%
Q3 2021$3,376,000
+75.0%
96,288
+7.2%
0.00%0.0%
Q2 2021$1,929,000
+66.1%
89,800
+377.6%
0.00%0.0%
Q1 2021$1,161,000
+118.6%
18,802
+48.0%
0.00%
Q4 2020$531,00012,7000.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,485,638$22,222,0001.76%
EcoR1 Capital, LLC 5,376,134$48,063,0001.53%
Cormorant Asset Management, LP 1,679,442$15,014,0000.89%
CM Management, LLC 100,000$894,0000.68%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 596,800$5,335,0000.40%
PDT Partners, LLC 278,487$2,490,0000.19%
Ikarian Capital, LLC 116,600$1,043,0000.16%
HighVista Strategies LLC 20,659$185,0000.15%
Aristides Capital LLC 35,132$314,0000.14%
Parkwood LLC 71,932$643,0000.11%
View complete list of ATEA PHARMACEUTICALS INC shareholders